These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 31587298)

  • 21. Bacteriophage-mediated modulation of microbiota for diseases treatment.
    Zhang Y; Li CX; Zhang XZ
    Adv Drug Deliv Rev; 2021 Sep; 176():113856. PubMed ID: 34237403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Review of Phage Therapy for Bone and Joint Infections.
    Ferry T
    Methods Mol Biol; 2024; 2734():207-235. PubMed ID: 38066372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phage Therapy: Going Temperate?
    Monteiro R; Pires DP; Costa AR; Azeredo J
    Trends Microbiol; 2019 Apr; 27(4):368-378. PubMed ID: 30466900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propagation, Purification, and Characterization of Bacteriophages for Phage Therapy.
    Kosznik-Kwaśnicka K; Topka G; Mantej J; Grabowski Ł; Necel A; Węgrzyn G; Węgrzyn A
    Methods Mol Biol; 2024; 2738():357-400. PubMed ID: 37966610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Wake-Up Call: We Need Phage Therapy Now.
    Moelling K; Broecker F; Willy C
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30563034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phages & antibiotic resistance: are the most abundant entities on earth ready for a comeback?
    Hill C; Mills S; Ross RP
    Future Microbiol; 2018 May; 13():711-726. PubMed ID: 29792526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies.
    Liu D; Van Belleghem JD; de Vries CR; Burgener E; Chen Q; Manasherob R; Aronson JR; Amanatullah DF; Tamma PD; Suh GA
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34209836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage therapy for respiratory infections.
    Chang RYK; Wallin M; Lin Y; Leung SSY; Wang H; Morales S; Chan HK
    Adv Drug Deliv Rev; 2018 Aug; 133():76-86. PubMed ID: 30096336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriophages and its applications: an overview.
    Sharma S; Chatterjee S; Datta S; Prasad R; Dubey D; Prasad RK; Vairale MG
    Folia Microbiol (Praha); 2017 Jan; 62(1):17-55. PubMed ID: 27718043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards Inhaled Phage Therapy in Western Europe.
    Wienhold SM; Lienau J; Witzenrath M
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30909579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phage therapy for the treatment of human intestinal bacterial infections: soon to be a reality?
    Brüssow H
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):785-788. PubMed ID: 28612636
    [No Abstract]   [Full Text] [Related]  

  • 34. Phage Therapy Takes on Broad Applications.
    Mertz L
    IEEE Pulse; 2022; 13(5):9-15. PubMed ID: 36301810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of lytic phage infections inducing persistence.
    Sanchez-Torres V; Kirigo J; Wood TK
    Curr Opin Microbiol; 2024 Jun; 79():102482. PubMed ID: 38714140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage therapy administered noninvasively could be effective in thin tubes subject to episodic flow despite washout: a simulation study.
    Blanco C; Chen IA
    Phys Biol; 2019 Jul; 16(5):054001. PubMed ID: 31266001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phages and their potential to modulate the microbiome and immunity.
    Federici S; Nobs SP; Elinav E
    Cell Mol Immunol; 2021 Apr; 18(4):889-904. PubMed ID: 32901128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of the Immune Response to Phage Therapy.
    Krut O; Bekeredjian-Ding I
    J Immunol; 2018 May; 200(9):3037-3044. PubMed ID: 29685950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.
    Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY
    J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phage therapy of wound-associated infections.
    Zyman A; Górski A; Międzybrodzki R
    Folia Microbiol (Praha); 2022 Apr; 67(2):193-201. PubMed ID: 35028881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.